ライフサイエンスコーパス: Q wave MI

1 Q-wave MI was noted in 52% to 53%, and thrombolytic ther

2 = 0.003), all MI (2.5% vs. 3.9%, p = 0.02), Q-wave MI (0.1% vs. 0.8%, p = 0.002), stent thrombosis (

3 in 565 patients (54%) including death (9%), Q-wave MI (9%) and target vessel revascularization (36%)

4 y identified with coronary angiography after Q-wave MI, the culprit lesion after NQWMI has not been w

5 unclear if rates of long-term sequelae after Q-wave MI have improved.

6 s, bypass surgery in 13, arrhythmia in 3 and Q wave MI in 2.

7 rence in death (5.6% vs. 5.3%, p = 0.92) and Q wave MI rate (4.3% vs. 2.9%, p = 0.55) after the multi

8 able, the frequency of in-hospital death and Q wave MI was similar to that of a matched consecutive s

9 ence in death (1.4% vs. 0.7%, p = 0.26), and Q-wave MI (1.2% vs. 0%, p = 0.02) was lower following mu

10 it of normal (ULN) in 17.9% of patients, and Q-wave MI developed in 0.6%.

11 included 246 patients with a first anterior Q-wave MI.

12 alyzed 303 patients with previous (>16 days) Q-wave MI by ECG who underwent transthoracic echocardiog

13 97.3%, with 2.7% major complications (death, Q wave MI, coronary artery bypass graft surgery [CABG]).

14 At 1 year, the frequency of death, Q wave MI, CABG and severe angina at 1 year was similar

15 In-hospital composite cardiac events (death, Q-wave MI, urgent in-hospital revascularization) and 8 m

16 The rate of the composite end point (death, Q-wave-MI and target lesion revascularization) at 1-year

17 At six months, 6% of patients died, 1% had Q-wave MI, 17% had repeat TVR, and the overall rate of m

18 The frequencies of in-hospital Q-wave MI, coronary artery bypass graft surgery and deat

19 men and 976 men with unstable angina and non-Q wave MI at the time of enrollment were compared.

20 The proportion of unstable angina and non-Q wave MI for women was similar in the trial and Registr

21 mpared with men with unstable angina and non-Q wave MI have not been extensively studied.

22 2) The outcome with unstable angina and non-Q wave MI is related to severity of illness and not gend

23 evascularization for unstable angina and non-Q wave MI was similar for women and men.

24 uating patients with unstable angina and non-Q wave MI, little prospective information is available o

25 roportionately more men in the trial had non-Q wave MI than men in the Registry.

26 to the hospital with unstable angina or non-Q wave MI.

27 as a higher prevalence of periprocedural non-Q wave MI (28% vs. 16%, p = 0.009) in the multiple SVG g

28 vs. 0.06%, p = 0.009) and periprocedural non-Q wave MI (8.7% vs. 4.2%, p = 0.003) were more frequent

29 useful in risk stratifying patients with non-Q wave MI.

30 Non-Q-wave MI (CK-MB > 3 times normal) occurred in 14% of pa

31 Non-Q-wave MI (CK-MB > or = 5 times normal) was more frequen

32 Non-Q-wave MI with CPK-MB >8x ULN was also a strong predicto

33 ts consisted of 3 deaths, 2 acute MIs, 1 non-Q-wave MI, and 3 cases of CHF.

34 There were 28 patients (16%) who had a non-Q-wave MI.

35 tine evaluation were defined as having a non-Q-wave MI.

36 , and there is no specific ECG sign of a non-Q-wave MI.

37 incidence of peri-procedural Q-wave and non-Q-wave MI.

38 cardial infarction [MI] through 30 days; non-Q-wave MI through 24 h; and ipsilateral stroke or neurol

39 infarction [MI]) in patients who evolved non-Q-wave MI (NQMI) following thrombolytic therapy.

40 e end point of death, postprocedural MI, non-Q-wave MI after PCI hospitalization, or urgent target-le

41 h a significant reduction in the risk of non-Q-wave MI (unadjusted odds ratio 0.18, 95% confidence in

42 butable mainly to a greater frequency of non-Q-wave MI with acolysis (19.6% versus 7.9%, P=0.03).

43 8676 admissions with unstable angina or non-Q-wave MI were enumerated and, of these, 3318 patients w

44 ristics, (2) a higher rate of procedural non-Q-wave MI, and (3) similar TLR and overall major cardiac

45 rdial infarction (MI); positive group, 4 non-Q-wave MIs and 12 myocardial revascularizations; nondiag

46 antly higher frequency of periprocedural non-Q-wave MIs, and 3) equivalent repeat revascularization r

47 ciated with a reduced risk of procedural non-Q-wave MIs.

48 h a lower incidence of procedure-related non-Q-wave MIs (duration of pretreatment <1 day, 29% had MI;

49 The incidence of Q-wave MI was also higher with acolysis (5.4% versus 2.2

50 blation and stenting than PTCA, the rates of Q-wave MI and survival were device-independent.

51 event-free survival (freedom from dealth or Q wave MI) and relief of angina; however, the need for r

52 erence in death (2.2% versus 0.9%, P=.34) or Q-wave MI (1.4% versus 0.9%, P=.64) between the two grou

53 year mortality (2.5% vs. 3.5%, p = 0.49) or Q-wave MI (2.7% vs. 1.2%, p = 0.48), and the overall car

54 reduced (nonspecified) composite of death or Q-wave MI.

55 times normal), or type 3 (>8 times normal or Q-wave MI).

56 yzed 173 asymptomatic patients with previous Q-wave MI (>16 days) with echocardiographic quantitation

57 ted electrocardiographic evidence of a prior Q-wave MI, but who lacked a history of this diagnosis.

58 age of 69 years) with an initial recognized Q-wave MI from 1950 through 1989, we investigated time t